Sean Ellis serves as Executive at Entera Bio Ltd., where they oversee executive responsibilities. Since joining the company, Sean Ellis has executed 6 insider transactions totaling $114.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 9, 2026 involved purchasing 18,000 shares valued at $22.3K.
Sean Ellis currently holds 178,098 shares of Entera Bio Ltd. (ENTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean Ellis has been a net buyer of ENTX stock. They have purchased $114.8K and sold $0 worth of shares.
Sean Ellis's most recent insider trade was on Feb 9, 2026, when they purchased 18,000 shares at $1.24 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 21, 2023 | ENTX | $24.0K | Purchase | 40,000 | $0.60 | Discretionary |
| Nov 11, 2022 | ENTX | $15.9K | Purchase | 30,000 | $0.53 | Discretionary |
| Jul 21, 2022 | ENTX | $24.4K | Purchase | 14,900 | $1.64 | Discretionary |
| Jan 18, 2022 | ENTX | $28.1K | Purchase | 10,000 | $2.81 | Discretionary |